Llwytho...

Incorporation of RG1 epitope into HPV16L1-VLP does not compromise L1-specific immunity

The candidate pan-Human Papillomavirus (HPV) vaccine RG1-VLP are HPV16 major capsid protein L1 virus-like-particles (VLP) comprising a type-common epitope of HPV16 minor capsid protein L2 (RG1; aa17–36). Vaccinations have previously demonstrated efficacy against genital high-risk (hr), low-risk (lr)...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Vaccine
Prif Awduron: Schellenbacher, C., Huber, B., Skoll, M., Shafti-Keramat, S., Roden, R.B.S., Kirnbauer, R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6832690/
https://ncbi.nlm.nih.gov/pubmed/31147274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.05.011
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!